Keith Geraghty

Dr. Keith Geraghty, B.Sc., B.Sc., M.Dip., M.P.H., Ph.D., is a Honorary Research Fellow at the University of Manchester (UK) in the Centre for Primary Care. His main research interests are patient safety and harms, doctor-patient relations, medically unexplained illness and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). He holds a Ph.D. in Health Management, a Master of Public Health (Merit with award of Distinction in Dissertation) and a Master Postgraduate Diploma in Research Methodology. In addition to being a ME/CFS researcher, Dr. Geraghty lives with ME/CFS.

In 2012, Geraghty became the Founder Director of The ME/CFS Research Group, whose goal is to bring together researchers and clinicians to undertake innovative studies of ME/CFS.

Publications

2018

• 2018, Rethinking the treatment of chronic fatigue syndrome—A reanalysis and evaluation of findings from a recent major trial of graded exercise and CBT (Full Text)

2017

• 5 Oct 2017 - Guest blogger for Mind the Brain - The SMILE Trial Lightning Process for Children with CFS: Results too good to be true?
• 29 Aug 2017 - Myalgic encephalomyelitis/chronic fatigue syndrome patients’ reports of symptom changes following cognitive behavioural therapy, graded exercise therapy and pacing treatments: Analysis of a primary survey compared with secondary surveys by Keith Geraghty, Mark Hann, Stoyan Kurtev in Journal of Health Psychology
• 14 June 2017 - Editorial - "Further Commentary on the PACE Trial: Biased Methods and Unreliable Outcomes" by Keith Geraghty in Journal of Health Psychology

2016

• 6 Dec 2016, "Mind the Gap: Ethical Failures in the Treatment of Chronic Fatigue Syndrome" by Charlotte Blease & Keith Geraghty in Journal of Medical Ethics blog<(Full Text)
• 5 Dec 2016, "Epistemic injustice in healthcare encounters: evidence from chronic fatigue syndrome" by Blease C, Carel H. & Geraghty K. in Journal of Medical Ethics
• 23 Sept 2016, Editorial - "'PACE-Gate': When clinical trial evidence meets open data access"
• 15 Sept 2016, "Cognitive behavioural therapy in the treatment of chronic fatigue syndrome: A narrative review on efficacy and informed consent"
• 1 Aug 2016, "Chronic fatigue syndrome: is the biopsychosocial model responsible for patient dissatisfaction and harm?" in British Journal of General Practice
• 27 Jun 2016, "The ‘all in the mind’ myth of myalgic encephalomyelitis/chronic fatigue syndrome" in Nursing in Practice
• 1 May 2016, "Doing Research in Chronic Fatigue Syndrome with Chronic Fatigue." 12th International IACFS/ME Research and Clinical Conference Conference paper. Geraghty, K.
• 2016, "Chronic Fatigue Syndrome and the Biopsychosocial Model: Accounting for Harm in the Medical Encounter" Conference paper by Geraghty, K., & Esmail, A.

2015

• 7 Nov 2015, "Deviant cellular and physiological responses to exercise in Myalgic Encephalomyelitis and chronic fatigue syndrome" by Geraghty, K., & Twisk, F. in Jacobs Journal of Physiology

Online presence

• Twitter
• ResearchGate
• Facebook
• LinkedIn

Learn more

• May 2016 IACFSME Newsletter - Doing Research in Chronic Fatigue Syndrome with Chronic Fatigue Syndrome – Dr. Keith Geraghty

cognitive behavioral therapy (CBT) - A type of psychotherapy geared toward modifying alleged unhealthy thinking, behaviors or illness beliefs. One of the treatment arms used in the controversial PACE trial.

myalgic encephalomyelitis (M.E.) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.

cognition Thought processes, including attention, reasoning, and memory.

PACE trial A controversial study which claimed that CBT and GET were effective in treating "CFS/ME", despite the fact that its own data did not support this conclusion. Its results and methodology were widely disputed by patients, scientists, and the peer-reviewed scientific literature.

bias Bias in research is "a systematic deviation of an observation from the true clinical state". (Learn more: me-pedia.org)

PACE trial A controversial study which claimed that CBT and GET were effective in treating "CFS/ME", despite the fact that its own data did not support this conclusion. Its results and methodology were widely disputed by patients, scientists, and the peer-reviewed scientific literature.

cognitive behavioral therapy (CBT) - A type of psychotherapy geared toward modifying alleged unhealthy thinking, behaviors or illness beliefs. One of the treatment arms used in the controversial PACE trial.

biopsychosocial model (BPS) - A school of thought, usually based in psychology, which claims illness and disease to be the result of the intermingling of biological, psychological and social causes. (Learn more: me-pedia.org)

physiological Concerning living organisms, such as cells or the human body.  Physio logical (as in physio) is not to be confused with psych ological (emotional stress).

myalgic encephalomyelitis (M.E.) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.